VisionPoint Advisory Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VisionPoint Advisory Group's AMGN Position: Q2 2026 in Review
VisionPoint Advisory Group reduced its Amgen (AMGN) stake by 1.9% in Q2 2026, selling an estimated $21.9K and leaving 3,296 shares worth $1.19M. The position accounts for 0.19% of the portfolio, ranked #122.
VisionPoint Advisory Group first reported a position in AMGN in Q4 2020 and has held it in 16 quarters since. The position peaked at $2.05M in Q4 2020. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- VisionPoint Advisory Group held 3,296 shares of Amgen worth $1.19M as of Q2 2026.
- VisionPoint Advisory Group sold 64 Amgen shares in Q2 2026, an estimated $21.9K.
- Amgen made up 0.19% of VisionPoint Advisory Group's portfolio in Q2 2026, its #122 holding.
- VisionPoint Advisory Group first reported a position in Amgen in Q4 2020 and has held it in 16 quarters since.
- VisionPoint Advisory Group's Amgen position peaked at $2.05M in Q4 2020.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.